Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07443631) titled 'Assessment of HPHC Exposure in Smokers Switching to THS/TP18 With Different Device Variants' on Feb. 25.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: None (Open Label).

Primary Sponsor: Philip Morris Products S.A.

Condition: Smoking

Intervention: Other: THS1 (TP18 variant 1) Other: THS2 (TP18 variant 2) Other: THS3 (TP18 variant 3) Other: THS4 (TP18 variant 4) Other: THS5 (THS 3.0 reference device)

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: February 19, 2026

Target Sample Size: ...